Skip to content

Transurethral high power (80W) potassium-titanyl-phosphase (KTP) laser vapourisation of the prostate compared with holmium laser ablation of the prostate: a single-centre randomised controlled trial in patients with obst. benign prostatic hyperplasia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14776501
Enrollment
80
Registered
2006-09-29
Start date
2005-11-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery: Prostatectomy Surgery Prostatectomy

Interventions

Patients will be invited to participate in the study from the out-patient clinic at the time a decision for surgical intervention has been made. They will have 2-3 weeks to consider whether or not the

Sponsors

Record Provided by the NHSTCT Register - 2006 Update - Department of Health (UK)
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: All patients will undergo routine assessment to include uroflowmetry, prostate size assessment, PSA testing and an IPSS score. Those between the ages of 55-75 and have Qmax flow rates of 12 (moderate-severe LUTS) and have PSA measurements within the normal range will be eligible for the study. Patients with prostate volumes of between 40-120 cc will be deemed suitable for laser ablation surgery.

Exclusion criteria

Exclusion criteria: Patients with prostate volumes of greater than 120 cc may require open surgery and those with prostate volumes of < 40 cc may simply require bladder neck incision and are therefore exclusion criteria. Patients presenting with chronic urinary retention will be excluded from the study. These patients may have atonic bladders and voiding difficulties following the procedure may be more difficult to interpret for the purposes of the study.

Design outcomes

Primary

MeasureTime frame
Improvements in flow rates and a reduction in IPSS scores

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026